V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70079073 | 70143536 | 1.8 | 26.1 | Curative (C) | 2019-08-13 | 2019-10-19 | Gemcitabine + Capecitabine | 99 | 0 | ALL INT GUIDE B INT MAINT | 100747802 |
| 70099791 | 70141079 | 1.75 | 53 | null | 2017-11-19 | 2017-11-21 | null | 99 | 0 | ALEMTUZUMAB | 100292976 |
| 70104157 | 70066124 | 1.68 | 89.6 | Curative (C) | 2019-03-27 | 2019-04-02 | null | null | 0 | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE + GO | 100744091 |
| 150015925 | 150008615 | 1.62 | 83 | Curative (C) | 2017-07-20 | 2017-07-20 | null | 01 | 0 | TEMOZOLOMIDE + RT | 100801722 |
| 150012840 | 150007037 | null | 3.5 | Adjuvant (A) | 2017-05-05 | 2017-05-11 | Temozolomide + RT | 02 | 0 | TEMOZOLOMIDE + RT | 101174273 |
| 70055185 | 70114713 | 1.88 | 85.5 | Palliative (P) | 2018-05-12 | 2018-05-12 | BENDAMUSTINE + BORTEZOMIB | N | 0 | ALL RELAPSE: CYCLOPHOSPHAMIDE + CYTARABINE + NAVITOCLAX + VENETOCLAX | 100657201 |
| 70097201 | 70114463 | 1.8 | 76.9 | Curative (C) | 2018-05-21 | 2018-12-17 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE | null | 0 | CARBOPLATIN + FLUOROURACIL | 101063080 |
| 80069027 | 80052557 | 1.63 | 10.1 | Curative (C) | 2019-11-30 | 2020-01-27 | null | 01 | 0 | DOCETAXEL | 101787310 |
| 70074624 | 70099897 | null | null | Curative (C) | 2017-06-18 | 2017-11-19 | ALL Relapse Blinatumomab | 02 | 0 | NOT MATCHED | 101678364 |
| 70074511 | 70099824 | 1.77 | 82 | Curative (C) | 2019-01-11 | 2019-02-04 | Brentuximab | N | 0 | BRENTUXIMAB | 100410184 |
| 70065633 | 70096138 | 1.7 | 107.8 | Curative (C) | 2016-10-18 | 2016-11-10 | CHOP R | N | 0 | CHOP R | 101509511 |
| 70098171 | 70063468 | 1.05 | 51 | Curative (C) | 2019-02-15 | 2019-02-22 | ALL UKALL2011 TRIAL | 01 | 0 | ALL UKALL2011 TRIAL | 101837654 |
| 70101109 | 70064899 | 1.7 | 68 | Curative (C) | null | 2019-06-18 | null | null | 0 | UKALL60+ | 101375330 |
| 70068261 | 70154393 | 1.63 | 81 | Curative (C) | 2019-07-10 | 2020-01-08 | CHOP R - 21 days | 02 | 0 | CHOP R | 100838484 |
| 80063144 | 80051409 | 0 | 101.4 | Curative (C) | 2017-10-02 | 2017-10-03 | Carboplatin + Etoposide iv&po | 01 | 0 | NIRAPARIB | 101727590 |
| 80050596 | 80047700 | null | 13.3 | null | 2015-10-31 | 2015-10-31 | WT SIOP 2002 01 post op Vinc alone | 01 | 0 | FLUOROURACIL + IRINOTECAN | 100281714 |
| 80055927 | 80043577 | 1.67 | 55 | null | 2017-03-16 | 2018-10-11 | FLUOROURACIL + OXALIPLATIN | 01 | 0 | TRIAL | 101014289 |
| 80007656 | 80035308 | 0 | 20.1 | null | 2018-08-11 | 2018-10-20 | CYCLOPHOSPHAMIDE | 01 | 0 | CISPLATIN + DOXORUBICIN + METHOTREXATE + VINBLASTINE | 100597634 |
| 70074592 | 70188325 | 1.82 | 64.3 | Disease modification (D) | null | 2022-04-09 | CHOP R - 21 days | N | 0 | CHOP R | 101220109 |
| 70071141 | 70170406 | 1.6 | null | Curative (C) | 2017-05-06 | 2017-05-06 | CHOP R - 21 days | N | 0 | CHOP R | 101316441 |
| 70079498 | 70163117 | 0 | 21 | Curative (C) | 2019-06-16 | 2019-06-16 | Ipilimumab | 2 | 0 | IGEV R | 101052931 |
| 70075618 | 70156089 | 1.56 | 115 | 03 | 2017-04-21 | 2018-04-09 | Brentuximab | N | 0 | BRENTUXIMAB | 101099583 |
| 70065803 | 70130733 | 1.74 | 68.4 | 03 | 2019-07-04 | 2020-02-08 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | 0 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100405095 |
| 70098782 | 70140730 | 1.82 | 49.8 | null | null | 2016-05-02 | null | 01 | 0 | AZACITIDINE + VENETOCLAX | 100875275 |
| 70099607 | 70141026 | 1.6 | 101 | null | 2018-09-28 | 2018-12-22 | null | null | 0 | BEACOPP | 101123755 |
| 70075098 | 70100142 | 1.62 | 89 | Curative (C) | 2018-05-07 | 2018-05-13 | ALL Interfant 06 MARMA: Ph I | 02 | 0 | CISPLATIN + GEMCITABINE + RITUXIMAB | 100920589 |
| 70089155 | 70056964 | 1.59 | 64 | null | 2018-06-29 | 2018-06-30 | FLAIR trial | 01 | 1 | FLAIR TRIAL | 100539296 |
| 10476432 | 10036089 | 1.7 | 66.6 | null | null | 2016-01-15 | null | 02 | 2 | LENALIDOMIDE | 100941545 |
| 160015156 | 160007501 | 1.55 | 107.9 | null | 2015-06-11 | 2015-07-09 | Olaparib | 02 | 2 | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100211062 |
| 70023770 | 70018187 | 1.67 | 71 | Curative (C) | 2019-06-03 | 2019-06-07 | CHOP R - 21 days | N | 2 | CHOP R | 101083294 |
| 70021631 | 70016616 | 1.9 | 90.3 | Curative (C) | 2018-02-12 | 2018-02-16 | CHOP R - 21 days | N | 2 | CHOP R | 100955348 |
| 160009525 | 160004388 | 1.62 | 72.4 | Palliative (P) | 2016-03-07 | 2016-03-28 | Carboplatin + Pemetrexed | 02 | 2 | CARBOPLATIN + PEMETREXED | 100076751 |
| 160012833 | 160006200 | 1.86 | 97.9 | Neo-adjuvant (N) | 2016-11-04 | 2016-12-15 | Cisplatin + Pemetrexed | null | 2 | CISPLATIN + PEMETREXED | 100089443 |
| 160013355 | 160006494 | 1.8 | 87.6 | Palliative (P) | 2018-04-18 | 2018-04-30 | DOXORUBICIN | 02 | 2 | ETOP 13-18 BEAT-MESO TRIAL | 100691443 |
| 160014966 | 160007393 | null | 63.5 | null | 2021-04-22 | 2021-06-15 | Cisplatin + Pemetrexed | 02 | 2 | CISPLATIN + PEMETREXED | 101822031 |
| 70020396 | 70015650 | 1.77 | 83.9 | Curative (C) | 2018-01-31 | 2018-02-14 | CHOP R - 21 days | N | 2 | CHOP R | 100446125 |
| 70031696 | 70023769 | 1.54 | 88.8 | Curative (C) | 2016-11-06 | 2016-11-26 | Bendamustine+Rituximab (1st Course) | 02 | 2 | BENDAMUSTINE + RITUXIMAB | 101377778 |
| 70031846 | 70023879 | 1.8 | 98.8 | Disease modification (D) | 2016-10-28 | 2016-10-30 | Bendamustine+Rituximab (1st Course) | N | 2 | BENDAMUSTINE + RITUXIMAB | 100672366 |
| 70042777 | 70031406 | 1.54 | 91.2 | null | 2021-11-30 | 2021-11-30 | Rituximab | 02 | 2 | RITUXIMAB | 101415407 |
| 70061082 | 70039228 | 1.57 | 70.3 | 03 | 2019-07-28 | 2019-07-28 | CVP R | 02 | 2 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100671551 |
| 70061131 | 70039258 | 1.64 | 80.6 | null | 2017-01-19 | 2017-01-29 | CVP R | 02 | 2 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101075555 |
| 70021720 | 70016686 | 1.58 | 94 | Curative (C) | 2016-04-15 | 2016-04-16 | CHOP R | 02 | 2 | CHOP R | 100437499 |
| 70083571 | 70069373 | null | null | Palliative (P) | 2016-05-06 | 2016-05-08 | VDT-PACE | N | 2 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 100172396 |
| 10410404 | 10057067 | 1.66 | 81.5 | 03 | 2021-05-24 | 2021-05-24 | CAR-T Tecartus + Cyclophosphamide + Fludarabine | 02 | 2 | BEVACIZUMAB | 101660431 |
| 70028665 | 70147553 | 1.51 | 74.7 | Curative (C) | 2018-09-06 | 2018-09-06 | Rituximab (Maintenance) | 02 | 2 | RITUXIMAB | 101590650 |
| 70029239 | 70147698 | 1.76 | 61 | 03 | 2018-08-20 | 2019-02-11 | Rituximab (SUBCUTANEOUS Maintenance) | N | 2 | RITUXIMAB | 100278482 |
| 70060296 | 70153166 | 1.7 | 63 | Not known (9) | null | 2018-08-16 | Bortezomib +/- Dexamethasone | 2 | 2 | BORTEZOMIB | 101382529 |
| 70031047 | 70177831 | 1.66 | 57 | Neo-adjuvant (N) | 2020-07-22 | 2020-08-01 | Rituximab | 02 | 2 | RITUXIMAB | 100564408 |
| 90027396 | 90012178 | 1.53 | 96 | Neo-adjuvant (N) | 2017-10-08 | 2017-10-15 | CARBOPLATIN + PACLITAXEL | N | 2 | CARBOPLATIN + PACLITAXEL | 101367612 |
| 90027582 | 90012260 | 1.58 | 54.2 | Adjuvant (A) | 2018-05-07 | 2018-05-16 | CARBOPLATIN + PACLITAXEL | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101066120 |